Skip to content

Immunity against SARS-Coronavirus-2 in breastmilk

Immunity against SARS-Coronavirus-2 in breastmilk - COVID MILK - POWER MILK Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON54955
Enrollment
5000
Registered
2020-09-22
Start date
2020-10-01
Completion date
Unknown
Last updated
2025-09-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronavirus COVID-19

Interventions

None listed

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Lactating women - For the follow-up study: participants who recieve a COVID-19 vaccination

Exclusion criteria

Exclusion criteria: • No written informed consent

Design outcomes

Primary

MeasureTime frame
IgG and IgA against SARS-CoV2 will be determined in the collected blood samples. Secretory IgA will be assessed in breast milk samples. Cortisol in hair will be measured

Secondary

MeasureTime frame
All the data out of the questionnaire about general health, physical activity, COVID-19 symptomens, diet, perceived stress.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)